Tearsheet

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0

Megatrend and thematic drivers
Megatrends include Healthcare Real Estate. Themes include Post-Acute Care Real Estate.

Weak multi-year price returns
3Y Excs Rtn is -21%

Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 62%

Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 28x

Stock price has recently run up significantly
6M Rtn6 month market price return is 173%, 12M Rtn12 month market price return is 270%

Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 140%

High stock price volatility
Vol 12M is 101%

Short seller report
Hindenburg Research report on 11/4/2024.

Key risks
PACS key risks include [1] potential NYSE delisting stemming from its failure to timely file financial reports and a necessary accounting restatement, Show more.

0 Megatrend and thematic drivers
Megatrends include Healthcare Real Estate. Themes include Post-Acute Care Real Estate.
1 Weak multi-year price returns
3Y Excs Rtn is -21%
2 Debt is significant
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 62%
3 Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 28x
4 Stock price has recently run up significantly
6M Rtn6 month market price return is 173%, 12M Rtn12 month market price return is 270%
5 Valuation getting more expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 140%
6 High stock price volatility
Vol 12M is 101%
7 Short seller report
Hindenburg Research report on 11/4/2024.
8 Key risks
PACS key risks include [1] potential NYSE delisting stemming from its failure to timely file financial reports and a necessary accounting restatement, Show more.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

PACS (PACS) stock has lost about 10% since 12/31/2025 because of the following key factors:

1. PACS Group, Inc. reported an earnings per share (EPS) miss for its fourth quarter of 2025, falling short of the Zacks Consensus Estimate by 9.47% with reported EPS of $0.43 against an estimate of $0.48. Despite strong revenue growth of 12.4% year-over-year to $1.36 billion, the market reacted negatively, leading to a single-day stock decline of 12.38% on February 26, 2026, the day the results were released.

2. The company faced challenges from rising operational costs and underperforming newer facilities, as highlighted during the Q4 2025 earnings call. The cost of services increased by 25% and General & Administrative expenses rose by 21% in 2025. New acquisition cohorts exhibited lower occupancy rates, with ramping facilities at 86.3% and new facilities at 81.1%, indicating that these low-occupancy, low-margin acquisitions were weighing on short-term financial results.

Show more

Stock Movement Drivers

Fundamental Drivers

The -11.7% change in PACS stock from 12/31/2025 to 4/13/2026 was primarily driven by a -17.8% change in the company's Shares Outstanding (Mil).
(LTM values as of)123120254132026Change
Stock Price ($)38.3933.89-11.7%
Change Contribution By: 
Total Revenues ($ Mil)5,2890.0%
Net Income Margin (%)3.6%0.0%
P/E Multiple27.70.0%
Shares Outstanding (Mil)129157-17.8%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

12/31/2025 to 4/13/2026
ReturnCorrelation
PACS-11.7% 
Market (SPY)-5.4%25.2%
Sector (XLV)-4.4%19.1%

Fundamental Drivers

The 146.8% change in PACS stock from 9/30/2025 to 4/13/2026 was primarily driven by a 0.0% change in the company's P/E Multiple.
(LTM values as of)93020254132026Change
Stock Price ($)13.7333.89146.8%
Change Contribution By: 
Total Revenues ($ Mil)5,2890.0%
Net Income Margin (%)3.6%0.0%
P/E Multiple27.70.0%
Shares Outstanding (Mil)21415736.9%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

9/30/2025 to 4/13/2026
ReturnCorrelation
PACS146.8% 
Market (SPY)-2.9%-3.6%
Sector (XLV)6.8%4.1%

Fundamental Drivers

The 201.5% change in PACS stock from 3/31/2025 to 4/13/2026 was primarily driven by a 0.0% change in the company's P/E Multiple.
(LTM values as of)33120254132026Change
Stock Price ($)11.2433.89201.5%
Change Contribution By: 
Total Revenues ($ Mil)5,2890.0%
Net Income Margin (%)3.6%0.0%
P/E Multiple27.70.0%
Shares Outstanding (Mil)21415736.9%
Cumulative Contribution0.0%

LTM = Last Twelve Months as of date shown

Market Drivers

3/31/2025 to 4/13/2026
ReturnCorrelation
PACS201.5% 
Market (SPY)16.3%12.1%
Sector (XLV)2.7%13.7%

Fundamental Drivers

null
null

Market Drivers

3/31/2023 to 4/13/2026
ReturnCorrelation
PACS  
Market (SPY)63.3%13.0%
Sector (XLV)19.7%18.6%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
PACS Return----43%193%-12%47%
Peers Return12%-15%64%8%59%22%229%
S&P 500 Return27%-19%24%23%16%-0%81%

Monthly Win Rates [3]
PACS Win Rate---67%58%50% 
Peers Win Rate50%47%64%53%67%50% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
PACS Max Drawdown----44%-41%-21% 
Peers Max Drawdown-5%-25%-11%-7%-12%-3% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-7% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: ENSG, BKD, NHC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 4/13/2026 (YTD)

How Low Can It Go

PACS has limited trading history. Below is the Health Care sector ETF (XLV) in its place.

Unique KeyEventXLVS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-16.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven19.1%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven599 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-28.8%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven40.4%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven116 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-15.8%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven18.8%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven326 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-40.6%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven68.3%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven1,100 days1,480 days

Compare to ENSG, BKD, NHC

In The Past

SPDR Select Sector Fund's stock fell -16.1% during the 2022 Inflation Shock from a high on 4/8/2022. A -16.1% loss requires a 19.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About PACS (PACS)

We are a leading post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities. Founded in 2013, we are one of the largest skilled nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. We also provide senior care, assisted living, and independent living options in some of our communities. Our significant historical growth has been primarily driven by our expertise in acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, high value-add short-term transitional care skilled nursing facilities. We believe our success is driven in significant part by our decentralized, local operating model, through which we empower local leaders at each facility to operate their facility autonomously and deliver excellence in clinical quality and a superior experience for our patients. We provide our independently operated facilities with a comprehensive suite of technology, support, and back-office services that allow local leadership teams to focus more of their time and effort on providing quality care to patients. We believe our operating model delivers value to all of our healthcare stakeholders, including patients and families, referring providers, payors, and administrators and clinicians. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after they have been discharged from the hospital. This ecosystem ranges from higher acuity, higher-cost settings, such as long-term acute care hospitals and inpatient rehabilitation facilities, to lower acuity, lower-cost settings, such as assisted living facilities, and home health. Skilled nursing facilities (SNFs) are positioned at the center of this ecosystem and play an essential role in providing cost efficient facility-based care to patients that have been discharged from hospitals but still require 24-hour in-patient services. SNFs can provide both long-term custodial care and higher value short-term transitional care. The SNF industry is large and growing, with the Centers for Medicare & Medicaid Services (CMS) expecting total industry expenditures to increase from $193.6 billion in 2022 to $283.3 billion in 2031, representing a compound annual growth rate (CAGR) of 4.3%. Based on the number of facilities as reported by CMS, we are one of the largest SNF operators in the United States. We are primarily focused on providing higher value short-term transitional care and believe we are uniquely positioned to capitalize on the current underlying trends within the SNF industry and to capture a growing portion of the expected demand. We believe that healthcare is local and we operate through a decentralized model, recognizing that each patient, facility, and community is unique. To that end, we believe that our local leaders and employees understand the distinct needs and priorities of their patients, staff, and facilities and are best positioned to make clinical and operational decisions in order to optimize patient outcomes and experience. To facilitate this, each of our facilities operates independently, led by a facility administrator and his or her interdisciplinary team of medical directors, nurses, therapists, specialty consultants, and operators. To assist these local teams in achieving their best clinical and operating potential, we provide each facility with access to PACS Services. PACS Services is a comprehensive suite of offerings, including accounting, finance, human resources, payroll, accounts receivable and payable, legal, and risk management services, as well as a robust suite of technology tools. We operate in a highly regulated industry with stringent regulatory compliance obligations, which requires robust regulatory compliance operations. Failure to operate in compliance with applicable laws and regulations could require significant expenditures and result in regulatory deficiencies and other regulatory penalties. PACS Services functions to support our regulatory compliance obligations across our organization, including through controlled billing and cost reporting practices and legal, risk management, and compliance support. PACS Services also provides teams of regional professionals available as resources to each facility, including a regional vice president (RVP) and regional clinical and non-clinical directors and consultants. We developed PACS Services to be a resource to help reduce administrative burden so that local leadership teams can focus on making decisions that improve the care, well-being, and quality of life of their patients. We believe that talented local leadership is critical to the success of our model of independently operated, centrally supported facilities. At the facility level, administrators are effectively the chief executive officers, and together with other local licensed professionals, are ultimately responsible for the operations of their respective facilities. We seek to recruit, train, and reward dynamic administrators for our facilities, and rely on them to work with their interdisciplinary teams to implement policies and procedures that are appropriate and effective and result in positive outcomes. We support the delivery of excellent care by building excellent teams. We believe our model attracts high caliber, entrepreneurial professionals who value having considerable autonomy, accountability, and aligned incentives. We provide these professionals with leadership and industry training, guidance, and operational support. Our model is intended to align local leaders’ incentives with facility and organizational success, encouraging them to dedicate themselves to the long-term future of their facilities. To create such alignment, we have developed an administrator compensation structure that prioritizes quality of care and operational and financial performance. Our administrators understand that a well-performing facility is the result of providing quality care in an environment of healing and caring, and one that is appropriately staffed, supplied, and equipped to meet the needs of its patients. This dedicated focus by our administrators and their local teams on patient outcomes drives demand for our services and can ultimately result in higher patient census and profitability. We also seek to provide opportunities for upward career mobility, with many of our administrators being promoted from within our company to roles of increasing levels of responsibility. Our culture of meritocracy and pride of ownership has helped us retain experienced facility administrators as well as RVPs who had average industry experience of 12.1 years, as of December 31, 2023. For the year ended December 31, 2023, we had a voluntary turnover rate of 3.1% among our facility administrators. Excellence in clinical quality and experience for our patients is at the forefront of our mission. We believe our focus on quality is reflected in our CMS Quality Measures (QM) Star rating, occupancy rate, and skilled mix by nursing patient days (which refers to the number of days our Medicare and managed care patients receive skilled nursing services at SNFs as a percentage of the total number of days that patients from all payor sources receive skilled nursing services at SNFs for any given period). The QM Star rating is a number between 1 and 5 that is assigned to SNFs that participate in Medicare or Medicaid, and is based on an aggregate score across a range of quality reporting program requirements. As of December 31, 2023, our average QM Star rating across all our facilities was 4.1 Stars, compared to the industry average of 3.6 Stars. For the years ended December 31, 2023, 2022 and 2021, our average occupancy rate across our Mature facilities, which we define as facilities purchased more than 36 months prior to the measurement date, was 93%, 92%, and 88%, respectively, compared to the industry average of 76%, 74% and 71%. For the year ended December 31, 2023, our skilled mix by nursing patient days was 32%. We have historically grown primarily through our disciplined and balanced acquisition strategy. We aim to create value by identifying and acquiring underperforming custodial care facilities and converting them into higher-value short-term transitional care facilities by investing in clinical teams and processes and upgrading technology, equipment, training, staffing, aesthetics, and other aspects of the business. The resources and guidance offered by PACS Services is key to rapid integration of new facilities and provides our local leadership teams with an effective technology infrastructure, support tools, and regional support teams that allow local leadership to focus on operational improvements. Our facilities generally undergo an up to three-year post-acquisition transition period. During this period, we seek to implement best practices designed to realize and sustain the facility’s full potential. These practices often result in significant improvements to clinical quality and other operational metrics, including skilled mix, occupancy rates and payor contracting. We believe the results of our acquisition strategy are demonstrated by our high average QM Star rating and occupancy rate for Mature facilities of 4.2 and 93%, respectively, as of December 31, 2023. As of December 31, 2023, the average QM Star rating and occupancy rate for New facilities, which we define as facilities purchased less than 18 months prior to the measurement date, was 3.9 and 87%, respectively. Our portfolio of owned and leased properties is strategically located in nine states: Arizona, California, Colorado, Kentucky, Missouri, Nevada, Ohio, South Carolina and Texas. We anticipate that available acquisition opportunities will enable us to further penetrate our reach into these nine states and to enter new states in the future. We believe our current markets are attractive and that the states in which we operate each has unique benefits, such as favorable reimbursement dynamics, high barriers to entry, or population growth of adults aged 65 and older, which is our primary patient demographic. We generally look for similar attributes in new markets that we enter. As of December 31, 2023, we leased 165 facilities, directly owned the real estate at 29 facilities, and owned partial interests in an additional 14 facilities through joint ventures managed by third parties. As we continue to grow, we intend to explore additional purchases of real-estate assets, through purchase options or right-of-first refusals in existing leases, as well as acquisitions and de novo construction of purpose-built facilities. For the year ended December 31, 2023, we generated total revenue of $3.1 billion, representing a CAGR of 63.3% over the last three years. A substantial portion of our revenue is generated from payments from third-party payors, including Medicare and Medicaid, which represent our largest sources of revenue and accounted for 38.6% and 37.6% of our routine revenue for the year ended December 31, 2023, respectively. For the year ended December 31, 2022, we generated revenue of $2.4 billion, and Medicare and Medicaid accounted for 47.6% and 30.2% of our total revenue, respectively. For the year ended December 31, 2023, we generated total net income of $112.9 million, total operating expense of $2.9 billion and Adjusted EBITDA of $237.5 million, representing a CAGR of 53.4%, 63.7%, and 51.1%, respectively, over the last three years. For the year ended December 31, 2022, our total operating expenses were $2.2 billion, and we generated net income of $150.5 million and Adjusted EBITDA of $255.5 million. As of December 31, 2023, we had total long-term liabilities of $3.0 billion. Adjusted EBITDA is a non-GAAP financial measure. --- We were initially incorporated on December 17, 2012 as Providence Group, Inc., a California corporation. On June 30, 2023, we undertook a reorganization in connection with our entry into a new credit agreement. Pursuant to this reorganization, PACS Group, Inc., which was incorporated on March 24, 2023 as a Delaware corporation, became the parent entity for our organization. --- PACS Group, Inc. is a holding company with operating subsidiaries that provide skilled nursing, senior living, as well as other ancillary businesses. Each facility is structured as an operating subsidiary under one of our two subsidiary holding companies: Providence Group, Inc. and Providence Group NH, LLC. Subsidiaries of Providence Group, Inc. are currently operating subsidiaries (facilities) with mortgage loans insured by the U.S. Department of Housing and Urban Affairs. Subsidiaries of Providence Group NH, LLC are currently operating subsidiaries (facilities) without such mortgage loans. PACS Group, Inc. and its subsidiaries that are not licensed healthcare providers do not provide healthcare services to patients, residents or any other person, and do not direct or control the provision of services provided. All healthcare services are provided solely by applicable subsidiaries that are licensed healthcare providers, under the direction and control of licensed healthcare professionals in accordance with applicable law. Our principal executive offices are located at 262 N. University Ave, Farmington, Utah.

AI Analysis | Feedback

PACS is like a Marriott or Hilton for skilled nursing facilities, operating a large network of decentralized care centers with central support.

AI Analysis | Feedback

  • Skilled Nursing Care: Providing specialized medical and rehabilitative services for patients requiring 24-hour in-patient services, including short-term transitional care after hospital discharge and long-term custodial care.
  • Assisted Living: Offering residential care and support for seniors who need assistance with daily activities.
  • Independent Living: Providing housing and a community environment for self-sufficient seniors.

AI Analysis | Feedback

PACS primarily sells its services to individuals (patients and residents) in need of post-acute and senior care. The company serves the following categories of customers:

  1. Individuals requiring Short-Term Transitional Skilled Nursing Care: These are patients who have been discharged from hospitals but still require 24-hour in-patient services to recuperate from acute conditions, illnesses, or serious medical procedures. This is the company's primary focus and a growing segment of their business.
  2. Individuals requiring Long-Term Custodial Skilled Nursing Care: While PACS's strategy is to transform facilities into higher acuity short-term care, they also serve individuals who need extended skilled nursing services for chronic conditions or ongoing care.
  3. Seniors and Individuals seeking Assisted Living and Independent Living: In some of its communities, PACS provides senior care, assisted living, and independent living options for individuals who need varying levels of support, from minimal assistance to more comprehensive daily living aid, but typically not requiring the same intensity of medical care as skilled nursing patients.

AI Analysis | Feedback

NULL

AI Analysis | Feedback

Jason Murray, Co-Founder, CEO and Chairman

Jason Murray is the Co-Founder, CEO, and Chairman of PACS Group, Inc., which he co-founded with Mark Hancock in 2013. He has over 20 years of experience as an executive in acute and post-acute healthcare settings and is a licensed nursing home administrator. Before co-founding PACS, he worked as a healthcare executive and licensed nursing home administrator. Murray holds a master's degree in healthcare administration and was named 2023 Mountain West Entrepreneur of the Year by Ernst & Young.

Mark Hancock, Co-Founder, Executive Vice Chairman, and Interim Chief Financial Officer

Mark Hancock is a Co-Founder, Executive Vice Chairman, and Interim Chief Financial Officer of PACS Group, Inc. He co-founded the company with Jason Murray in 2013 and previously served as CFO from January 2013 until January 2024, when he was appointed Executive Vice Chairman. He was re-appointed interim CFO on September 3, 2025, following the resignation of the previous CFO. Hancock has over 20 years of experience as a finance professional. Prior to co-founding PACS, he worked as Vice President of Finance and Treasurer of Farm Credit Mid-America, a nursing home administrator at a facility affiliated with Plum Healthcare Group, Director of Corporate Finance for Steel Technologies Inc., and a Finance Manager for Ford Motor Company. He was also named a 2023 Mountain West Entrepreneur of the Year by Ernst & Young.

Josh Jergensen, President and Chief Operating Officer

Josh Jergensen is the President and Chief Operating Officer at PACS Group, Inc. He has been providing operational support to all facilities within the PACS portfolio since 2014. Jergensen is a licensed nursing home administrator and an approved preceptor in California, with more than 10 years of experience operating complex multi-story skilled nursing facilities.

John Mitchell, Chief Legal Officer and Secretary

John Mitchell serves as the Chief Legal Officer and Secretary for PACS Group, Inc., managing the company's legal department. He joined PACS in 2017. Previously, he held positions as Vice President, Legal at HCP, a NYSE-traded healthcare-focused real estate investment trust, and as Senior Vice President, Legal, and Chief Compliance Officer at Skilled Healthcare Group, a NYSE-traded skilled nursing company. He began his career at an international law firm with a focus on corporate, finance, and mergers and acquisitions.

Michelle Lewis, Executive Vice President, Chief Accounting Officer

Michelle Lewis has served as PACS Group, Inc.'s Executive Vice President, Chief Accounting Officer since January 2023. She joined the company in July 2018 and held various roles of increasing responsibility, including Controller. Before joining PACS, Ms. Lewis owned and operated her own certified public accounting firm and provided controller functions at a privately held healthcare organization.

AI Analysis | Feedback

The key risks to PACS's business are:

  1. High Dependence on Government Reimbursement Programs and Regulatory Compliance: A substantial portion of PACS's revenue is generated from payments from third-party payors, particularly Medicare and Medicaid, which together accounted for 76.2% of their routine revenue in 2023 and 77.8% of total revenue in 2022. The company operates in a highly regulated industry with stringent compliance obligations, and any changes to these government reimbursement programs or failure to comply with applicable laws and regulations could result in significant expenditures, regulatory penalties, and a material adverse effect on their financial performance and operations.

  2. Acquisition and Integration Strategy Risks: PACS's significant historical growth has been primarily driven by its strategy of acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, high value-add short-term transitional care facilities. The success of this strategy relies on their expertise in identifying suitable acquisition targets, investing in clinical teams and processes, and upgrading various aspects of the business, often involving an up to three-year post-acquisition transition period. Failure to successfully execute this acquisition and integration strategy, or to effectively convert facilities to higher-value care models, could impede their growth, operational improvements, and profitability.

AI Analysis | Feedback

null

AI Analysis | Feedback

The primary addressable market for PACS is the Skilled Nursing Facility (SNF) industry in the U.S. The Centers for Medicare & Medicaid Services (CMS) expects total industry expenditures for SNFs to increase from $193.6 billion in 2022 to $283.3 billion in 2031.

AI Analysis | Feedback

Expected Drivers of Future Revenue Growth for PACS

  • Strategic Acquisitions and Facility Transformation: PACS's historical growth has been primarily driven by its strategy of acquiring underperforming long-term custodial care skilled nursing facilities and transforming them into higher acuity, high value-add short-term transitional care facilities. This involves investing in clinical teams and processes, upgrading technology, and improving overall operations, which is expected to continue driving revenue growth as new facilities are integrated and optimized.
  • Improved Occupancy Rates and Skilled Mix: The company's operational model focuses on implementing best practices in acquired facilities, leading to significant improvements in clinical quality, occupancy rates, and skilled mix by nursing patient days (the percentage of Medicare and managed care patients). As new facilities mature and existing ones continue to optimize, these enhanced metrics are expected to contribute to increased revenue per patient day and overall revenue growth.
  • Overall Expansion of the Skilled Nursing Facility (SNF) Industry: PACS operates within a growing market, with the Centers for Medicare & Medicaid Services (CMS) projecting total SNF industry expenditures to increase at a compound annual growth rate (CAGR) of 4.3% from $193.6 billion in 2022 to $283.3 billion in 2031. As one of the largest SNF operators in the United States, PACS is well-positioned to benefit from this broader industry expansion.
  • Geographic Expansion: PACS anticipates further penetrating its reach into its current nine states and entering new states in the future through available acquisition opportunities. This geographic expansion will increase its total number of facilities and patient base, contributing to sustained revenue growth.

AI Analysis | Feedback

Outbound Investments

  • PACS has historically grown primarily through a disciplined acquisition strategy, identifying and acquiring underperforming long-term custodial care skilled nursing facilities.
  • The company focuses on converting acquired facilities into higher-value short-term transitional care facilities by investing in clinical teams, processes, technology, equipment, training, staffing, and aesthetics.
  • PACS intends to explore additional purchases of real-estate assets, through purchase options or right-of-first refusals in existing leases, as well as acquisitions and de novo construction of purpose-built facilities.

Capital Expenditures

  • The primary focus of capital expenditures is on implementing best practices in acquired facilities, including investments in clinical teams and processes, and upgrading technology, equipment, training, staffing, and aesthetics.
  • These expenditures aim to realize and sustain the full potential of facilities during an up to three-year post-acquisition transition period.

Trade Ideas

Select ideas related to PACS.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
PGNY_3312026_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG03312026PGNYProgynyDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
0.0%0.0%0.0%
CNC_3272026_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG03272026CNCCenteneDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
2.3%2.3%-0.6%
OSCR_3272026_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG03272026OSCROscar HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.0%3.0%-2.6%
WAT_3202026_Monopoly_xInd_xCD_Getting_Cheaper03202026WATWatersMonopolyMY | Getting CheaperMonopoly-Like with P/S Decline
Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple
-0.4%-0.4%-3.3%
GILD_3202026_Quality_Momentum_RoomToRun_10%03202026GILDGilead SciencesQualityQ | Momentum | UpsideQuality Stocks with Momentum and Upside
Buying quality stocks with strong momentum but still having room to run
1.6%1.6%-2.2%

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

PACSENSGBKDNHCMedian
NamePACS Ensign Brookdal.National. 
Mkt Price33.89200.3013.60169.60101.75
Mkt Cap5.311.53.22.64.3
Rev LTM5,2895,0583,1941,5184,126
Op Inc LTM31042587128219
FCF LTM15518017149152
FCF 3Y Avg21185-3010463
CFO LTM404564218185311
CFO 3Y Avg278429182135230

Growth & Margins

PACSENSGBKDNHCMedian
NamePACS Ensign Brookdal.National. 
Rev Chg LTM29.3%18.7%2.2%16.9%17.8%
Rev Chg 3Y Avg-18.7%5.2%12.3%12.3%
Rev Chg Q12.4%20.2%-3.4%4.6%8.5%
QoQ Delta Rev Chg LTM2.9%4.7%-0.8%1.1%2.0%
Op Mgn LTM5.9%8.4%2.7%8.5%7.1%
Op Mgn 3Y Avg5.2%7.9%1.7%6.8%6.0%
QoQ Delta Op Mgn LTM0.3%0.1%0.7%0.2%0.2%
CFO/Rev LTM7.6%11.2%6.8%12.2%9.4%
CFO/Rev 3Y Avg6.2%9.8%5.9%10.1%8.0%
FCF/Rev LTM2.9%3.6%0.5%9.8%3.2%
FCF/Rev 3Y Avg-0.0%4.4%-1.0%7.7%2.2%

Valuation

PACSENSGBKDNHCMedian
NamePACS Ensign Brookdal.National. 
Mkt Cap5.311.53.22.64.3
P/S1.02.31.01.71.4
P/EBIT17.024.9-122.715.616.3
P/E27.733.5-12.321.924.8
P/CFO13.120.414.814.214.5
Total Yield3.6%3.1%-8.1%6.0%3.4%
Dividend Yield0.0%0.1%0.0%1.5%0.1%
FCF Yield 3Y Avg-2.5%-2.6%5.9%2.5%
D/E0.70.21.70.00.4
Net D/E0.60.11.6-0.10.4

Returns

PACSENSGBKDNHCMedian
NamePACS Ensign Brookdal.National. 
1M Rtn-2.7%-4.5%-2.4%5.5%-2.6%
3M Rtn-18.4%13.4%23.0%27.2%18.2%
6M Rtn173.3%13.2%56.0%43.1%49.5%
12M Rtn270.0%56.8%136.5%88.2%112.4%
3Y Rtn47.3%104.6%235.0%216.5%160.5%
1M Excs Rtn-2.6%-7.0%-5.4%6.0%-4.0%
3M Excs Rtn-16.7%16.4%24.7%32.4%20.5%
6M Excs Rtn156.5%11.7%50.9%41.6%46.3%
12M Excs Rtn214.1%29.0%104.7%58.5%81.6%
3Y Excs Rtn-21.0%38.7%308.8%146.8%92.7%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil2025202420232022
Single Segment4,0903,111  
Additional funding  2129
Other revenues  12
Patient and resident service revenue  2,3991,136
Total4,0903,1112,4221,167


Net Income by Segment
$ Mil2025202420232022
Single Segment55113  
Total55113  


Price Behavior

Price Behavior
Market Price$33.89 
Market Cap ($ Bil)5.3 
First Trading Date04/11/2024 
Distance from 52W High-19.6% 
   50 Days200 Days
DMA Price$35.71$23.52
DMA Trendupdown
Distance from DMA-5.1%44.1%
 3M1YR
Volatility58.4%101.1%
Downside Capture0.59-0.33
Upside Capture26.03114.89
Correlation (SPY)21.6%6.9%
PACS Betas & Captures as of 3/31/2026

 1M2M3M6M1Y3Y
Beta1.120.681.07-0.340.650.31
Up Beta-1.930.580.601.841.020.03
Down Beta1.840.621.44-1.630.55-0.27
Up Capture58%71%63%134%102%24%
Bmk +ve Days7162765139424
Stock +ve Days8172759119237
Down Capture136%75%127%-147%-24%75%
Bmk -ve Days12233358110323
Stock -ve Days14253666131250

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with PACS
PACS257.3%100.9%1.67-
Sector ETF (XLV)8.1%16.3%0.3011.7%
Equity (SPY)18.7%13.7%1.068.4%
Gold (GLD)53.7%27.6%1.55-7.9%
Commodities (DBC)25.2%16.2%1.37-6.6%
Real Estate (VNQ)14.8%14.0%0.7614.2%
Bitcoin (BTCUSD)-11.7%43.0%-0.17-6.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with PACS
PACS9.0%85.7%0.61-
Sector ETF (XLV)6.5%14.6%0.2618.5%
Equity (SPY)11.1%17.0%0.5012.9%
Gold (GLD)21.8%17.8%1.01-0.1%
Commodities (DBC)11.7%18.8%0.51-1.3%
Real Estate (VNQ)3.7%18.8%0.1022.5%
Bitcoin (BTCUSD)4.6%56.6%0.30-0.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
Annualized
Return
Annualized
Volatility
Sharpe
Ratio
Correlation
with PACS
PACS4.4%85.7%0.61-
Sector ETF (XLV)9.7%16.5%0.4818.5%
Equity (SPY)13.9%17.9%0.6712.9%
Gold (GLD)14.2%15.9%0.74-0.1%
Commodities (DBC)8.8%17.6%0.42-1.3%
Real Estate (VNQ)5.2%20.7%0.2222.5%
Bitcoin (BTCUSD)67.5%66.9%1.07-0.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How

Short Interest

Short Interest: As Of Date3312026
Short Interest: Shares Quantity4.3 Mil
Short Interest: % Change Since 315202616.0%
Average Daily Volume0.8 Mil
Days-to-Cover Short Interest5.2 days
Basic Shares Quantity156.6 Mil
Short % of Basic Shares2.7%

Earnings Returns History

Expand for More
 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
2/26/2026-12.4%-14.6%-26.6%
9/11/202524.5%45.5%69.9%
11/6/2024-38.8%-30.5%-50.5%
8/12/202418.8%23.1%22.2%
5/13/20247.3%13.8%17.8%
SUMMARY STATS   
# Positive333
# Negative222
Median Positive18.8%23.1%22.2%
Median Negative-25.6%-22.6%-38.5%
Max Positive24.5%45.5%69.9%
Max Negative-38.8%-30.5%-50.5%

SEC Filings

Expand for More
Report DateFiling DateFiling
12/31/202502/27/202610-K
09/30/202511/19/202510-Q
06/30/202511/19/202510-Q
03/31/202511/19/202510-Q
12/31/202411/19/202510-K
09/30/202411/19/202510-Q
06/30/202408/12/202410-Q
03/31/202405/13/202410-Q
12/31/202304/12/2024424B4

Recent Forward Guidance [BETA]

Latest: Q4 2025 Earnings Reported 2/26/2026

Forward GuidanceGuidance Change
MetricLowMidHigh% Chg% DeltaChangePrior
2026 Revenue5.65 Bil5.70 Bil5.75 Bil7.5% Higher NewGuidance: 5.30 Bil for 2025
2026 Adjusted EBITDA555.00 Mil565.00 Mil575.00 Mil16.5% Higher NewGuidance: 485.00 Mil for 2025

Prior: Q3 2025 Earnings Reported 11/19/2025

null

Insider Activity

Expand for More
#OwnerTitleHoldingActionFiling DatePriceSharesTransacted
Value
Value of
Held Shares
Form
1Dilsaver, Evelyn S DirectBuy1126202529.9016,724499,997679,828Form
2Mitchell, John ToddChief Legal Officer & Sec.DirectSell1126202529.89159,5564,768,37922,588,386Form
3Jergensen, JoshuaPresident & COODirectSell317202634.2836,3351,245,64791,442,790Form